FSHD region gene 2 family member G, pseudogene (FRG2GP)

FRG2GP (FSHD region gene 2 family member G, pseudogene) is an annotated pseudogene belonging to the FRG2 gene family. Pseudogenes are gene sequences that resemble functional genes but lack protein-coding capacity due to disabling mutations. The FRG2GP locus is located near the D4Z4 repeat array on chromosome 4q and chromosome 10q, a region implicated in facioscapulohumeral muscular dystrophy (FSHD)[3][5]. Unlike FRG2, which is expressed in differentiating myoblasts in FSHD patients and may play a role in myogenesis or FSHD pathogenesis[3], FRG2GP itself has no demonstrated protein expression, biological function, disease relevance, or therapeutic target status. Its primary relevance is as a genomic annotation in the study of FSHD-linked chromatin structure and gene regulation[3]. Key points: - FRG2GP is a pseudogene, not a canonical receptor, enzyme, or therapeutic target[5][3]. - No known biological function, disease relevance, or drug interaction for FRG2GP[5][3]. - FRG2GP is not used in clinical decision-making or as a biomarker. - Inclusion of FRG2GP as a “target” is incorrect for molecular pharmacology. For structured databases or informatics usage, FRG2GP should be flagged as a non-target pseudogene, and references to it as a drug target or receptor are incorrect.

Other names

FRG2GPFSHD region gene 2 family member G, pseudogeneSome resources may refer generically to FRG2 locus-related pseudogenes, but “FRG2GP” is the precise gene symbol in annotation.